Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Sep;79(3):562-6.
doi: 10.1086/507567. Epub 2006 Jul 19.

Peters Plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase

Saskia A J Lesnik Oberstein  1 , Marjolein Kriek, Stefan J White, Margot E Kalf, Karoly Szuhai, Johan T den Dunnen, Martijn H Breuning, Raoul C M Hennekam
Affiliations

Peters Plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase

Saskia A J Lesnik Oberstein et al. Am J Hum Genet. 2006 Sep.

Erratum in

  • Am J Hum Genet. 2006 Nov;79(5):985

Abstract

Peters Plus syndrome is an autosomal recessive disorder characterized by anterior eye-chamber abnormalities, disproportionate short stature, and developmental delay. After detection of a microdeletion by array-based comparative genomic hybridization, we identified biallelic truncating mutations in the beta 1,3-galactosyltransferase-like gene (B3GALTL) in all 20 tested patients, showing that Peters Plus is a monogenic, primarily single-mutation syndrome. This finding is expected to put Peters Plus syndrome on the growing list of congenital malformation syndromes caused by glycosylation defects.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Overview of the location of the mutations in the B3GALTL gene and the results of the RT-PCR of RNA isolated from fibroblasts. A, Genes present in the 1.5-Mb deletion found in two brothers with Peters Plus syndrome. B, 15 exons of the B3GALTL gene, with the localization of the mutations. C, B3GALTL protein, which consists of a transmembrane region (TMR), a stem region (SR), and a catalytic domain (CD). Both mutations (c.1020+1G→A and c.437+5G→A) are located in the stem region. D, Result of the nested RT-PCR of exons 7–11 of the BGALTL gene, with RNA derived from myoblasts (WT), RNA from fibroblasts of a father heterozygous for the c.1020+1G→A mutation (Het), and RNA from fibroblasts of his affected son with c.1020+1G→Apat/delmat (Hom). The patient shows a smaller band compared with the WT band, which indicates a skip of exon 8. Sequence analysis of this band is shown. The vertical line indicates the end of exon 7 and the beginning of exon 9. The RT-PCR of the father shows, in addition to the WT band, a skipped product with much less intensity. E, Result of the RT-PCR encompassing exons 4–7 of the BGALTL gene, with RNA derived from lymphocytes of a control individual (WT) and a patient with a c.1020+1G→Amat/c.437+5G→Apat genotype (Het). In addition to a faint WT band, the patient shows a smaller product that lacks exon 5. The sequence analysis of this smaller band confirms the skip of exon 5.
Figure 2.
Figure 2.
Facial features of four patients with Peters Plus syndrome. Patients A and C are homozygous for the c.1020+1G→A mutation. Patient B has the c.1020+1G→Amat/c.437+5G→Apat genotype, and patient D has the c.1020+1G→Apat/delmat genotype. Note the Peters anomaly of the eyes, the long face, and the Cupid’s bow shape of the upper lip in all patients. Patients B and D have a repaired cleft lip and/or palate. Patient A is female; the rest are male.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

Web Resources

    1. Berkeley Drosophila Genome Project, http://www.fruitfly.org/seq_tools/splice.html (for the Splice Site Prediction by Neural Network)
    1. Carbohydrate-Active enZymes (CAZy), http://194.214.212.50/CAZY/fam/GT31.html
    1. dbEST, http://www.ncbi.nlm.nih.gov/dbEST/ (for the Expressed Sequence Tags database)
    1. dbSNP, http://www.ncbi.nlm.nih.gov/SNP/ (for SNP identification numbers rs9315120, rs877103, and rs877104)
    1. HUGO Gene Nomenclature Committee, http://www.gene.ucl.ac.uk/nomenclature/ (for B3GALTL)

References

    1. Wenniger-Prick LJJM, Hennekam RCM (2002) The Peters’ plus syndrome: a review. Ann Genet 45:97–103 - PubMed
    1. Knijnenburg J, Szuhai K, Giltay J, Molenaar L, Sloos W, Poot M, Tanke HJ, Rosenberg C (2005) Insights from genomic microarrays into structural chromosome rearrangements. Am J Med Genet A 132:36–40 - PubMed
    1. Ferlin A, Simonato M, Bartoloni L, Rizzo G, Bettella A, Dottorini T, Dallapiccola B, Foresta C (2003) The INSL3-LGR8/GREAT ligand-receptor pair in human cryptorchidism. J Clin Endocrinol Metab 88:4273–427910.1210/jc.2003-030359 - DOI - PubMed
    1. Tournier I, Paillerets BB, Sobol H, Stoppa-Lyonnet D, Lidereau R, Barrois M, Mazoyer S, Coulet F, Hardouin A, Chompret A, Lortholary A, Chappuis P, Bourdon V, Bonadona V, Maugard C, Gilbert B, Nogues C, Frebourg T, Tosi M (2004) Significant contribution of germline BRCA2 rearrangements in male breast cancer families. Cancer Res 64:8143–814710.1158/0008-5472.CAN-04-2467 - DOI - PubMed
    1. Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S, Foretova L, Soucek P, King MC (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295:1379–138810.1001/jama.295.12.1379 - DOI - PubMed

LinkOut - more resources